The company adjusted its full-year 2025 earnings to account for a legal provision of 402.5 billion JPY ($2.5 billion). More: Takeda takes .5B legal charge after pay-for-delay verdict, swings to loss for '25 Source: fierce
read moreThe FDA is going forward with an investigation into the safety of the abortion pill mifepristone, an initiative that could allow the Trump administration to impose restrictions on its use, The Wall Street Journal reports. More: As pro-life pressure ramps up
read moreEach year, the global oncology community descends on Chicago for ASCO, where buzzy data drops, practice-changing posters and packed sessions offer a look at where cancer care is headed next. In this week’s episode of “The Top Line,” Fierce Biotech’s
read more© 1994 - 2026 B.M. Pharmaceuticals